Inhibiting A beta toxicity in Alzheimer's disease by a pyridine amine derivative
Inhibiting A beta toxicity in Alzheimer's disease by a pyridine amine derivative
复制标题
吡啶胺衍生物抑制阿尔茨海默病中的 Aβ 毒性
DOI:
10.1016/j.ejmech.2019.02.052
复制
发表时间:
2019
影响因子:
6.7
通讯作者:
Wang Xiaoyong
中科院分区:
文献类型:
--
作者:
Zhu Zhenzhu;Yang Tao;Zhang Lei;Liu Lulu;Yin Enmao;Zhang Changli;Guo Zijian;Xu Chen;Wang Xiaoyong
Alzheimer's disease (AD) is a neurodegenerative disorder with no radical therapy. Aggregation of amyloidβ-peptide (Aβ) induced by various factors is associated with pathogenesis of AD. A pyridine amine derivative, 3-bis(pyridin-2-ylmethyl)aminomethyl-5-hydroxybenzyltriphenylphosphonium bromide (PAT), is synthesized. The inhibition of self- and metal-induced Aβaggregation by PAT is confirmed by thioflavine T fluorescence, circular dichroism spectroscopy, and TEM. Western blot, RT-PCR and fluorescence imaging indicate that PAT can alleviate the Aβ-induced paralysis, reduce the production of ROS, and protect the mitochondrial function in transgenicC. elegans. Genetic analyses indicate that heat shock protein is involved in the alleviation of Aβtoxicity. PAT also inhibits the activity of acetylcholinesterase inC. elegans. Morris water maze test shows that the memory and cognitive ability of APP/PS1 AD model mice are significantly improved by PAT. Bothin vitroandin vivostudies demonstrate that PAT is effective in counteracting Aβtoxicity and ameliorating cognitive functions in AD mice, and therefore a potential lead compound of anti-AD drugs.